But teens with ADHD more likely to have other negative outcomes, such as self-harm, compared with teens without ADHD
MONDAY, Oct. 17, 2022 (HealthDay News) — A diagnosis of attention-deficit/hyperactivity disorder (ADHD) does not appear to lower overall self-reported quality of life (QOL) among adolescents (aged 14 to 15 years), according to a study published online Oct. 13 in JAMA Network Open.
Luise Kazda, M.P.H., from the Sydney School of Public Health at the University of Sydney, and colleagues compared QOL in 393 matched adolescents with and without an ADHD diagnosis.
The researchers found that compared with adolescents without an ADHD diagnosis, those with ADHD reported similar QOL on the Child Health Utility 9D, general health, happiness, and peer trust. However, psychological sense of school membership, academic self-concept, and self-efficacy were worse for adolescents with an ADHD diagnosis. Adolescents with ADHD also displayed more negative social behaviors and were more likely to harm themselves (odds ratio, 2.53) versus adolescents without an ADHD diagnosis.
“Unfortunately, our results indicate no beneficial associations of an ADHD diagnosis with adolescents’ QOL, which is highly concerning,” the authors write. “It implies that the harms associated with an ADHD label (such as stigma, prejudice, deflection from other problems, or the perceived inability to change) may not be offset by benefits associated with the diagnosis or treatment.”
EHR-Enabled QI Intervention Improves Chlamydia, Gonorrhea Screening in Teens
Characteristics of Individuals Diagnosed With Autism Have Changed Since 2010
Low Levels of Placental Growth Factor in Pregnancy Linked to Subsequent ADHD in Offspring
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder
Rates of Drug Use-Associated Infective Endocarditis Declined From 2020 to 2022
Nonpharmacologic Therapy Cuts Opioid Use Disorder Risk With Low Back Pain
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Withdrawal From Medetomidine Increasingly Seen in ICUs